Skip to main content

Table 1 Prevalence of phylogenetic groups among E. coli isolates and prevalence of AR genotypes and phenotypes among each phylotype

From: High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran

Variables

no. of isolates in each phylotype (% among 106 E. coli isolates)

A

B1

B2

C

D

E

F

U

6 (5.6)

7 (6.6)

31 (29.2)

7 (6.6)

19 (17.9)

15 (14.1)

10 (9.4)

11 (10.3)

AR gene [no. (% among 106 E. coli isolates)]

Prevalence of AR gene; no. (% in each phylotype)

 blaTEM [95 (89.6)]

6 (100)

6 (85.7)

25 (80.6)

7 (100)

18 (94.7)

15 (100)

10 (100)

8 (72.7)

 blaSHV [7 (6.6)]

-

-

1 (3.2)

-

1 (5.2)

1 (6.6)

-

4 (36.3)

 blaCTX-M [47 (44.3)]

2 (33.3)

3 (42.8)

15 (48.3)

4 (57.1)

6 (31.5)

8 (53.3)

6 (60)

3 (27.2)

 blaCMY [1 (0.9)]

-

-

1 (3.2)

-

-

-

-

-

 Without AR gene [9 (8.4)]

-

1 (14.2)

5 (16.1)

-

-

-

-

3 (27.2)

AR phenotype [no. (% among 106 E. coli isolates)]

Prevalence of AR phenotype; no. (% in each phylotype)

 CP [59 (55.6)]

3 (50)

4 (57.1)

18 (57.6)

5 (71.4)

6 (31.5)

7 (46.6)

8 (80)

8 (72.7)

 AZT [88 (83)]

6 (100)

6 (85.7)

26 (83.8)

7 (100)

13 (67.4)

11 (73.3)

9 (90)

10 (90.9)

 CRO [82 (77)]

4 (66.6)

5 (71.4)

24 (77.4)

6 (87.7)

11 (57.8)

13 (86.6)

10 (100)

9 (81.8)

 CAZ [81 (76.4)]

5(83.3)

4 (57.1)

25 (80.6)

7 (100)

12 (63.1)

10 (66.6)

10 (100)

8 (72.7)

 CTX [94 (88.6)]

5 (83.3)

5 (71.4)

28 (90.3)

7 (100)

17 (89.4)

13 (86.6)

10 (100)

9 (81.8)

ESBL-producing strains [56 (52.8)]

2 (33.3)

5 (71.4)

14 (45.1)

3 (42.8)

9 (47.3)

10 (66.6)

8 (80)

5 (45.4)

Without AR phenotype [3 (2.8)]

-

1 (14.2)

-

-

1 (5.2)

1 (6.6)

-

-